GrippeAllemagneV4, Main, Exploration, bibRecord, 000031

[Influenza: special aspects in old age].

Identifieur interne : 000031 ( Main/Exploration ); précédent : 000030; suivant : 000032

[Influenza: special aspects in old age].

Auteurs : A. Kwetkat [Allemagne] ; A. Leischker [Allemagne] ; H J Heppner [Allemagne]

Source :

Zeitschrift fur Gerontologie und Geriatrie [ 1435-1269 ] ; 2018.

RBID : pubmed:29951833

Descripteurs français

KwdFr :
- Adjuvants immunologiques (MeSH), Adulte d'âge moyen (MeSH), Allemagne (épidémiologie), Femelle (MeSH), Grippe humaine (immunologie), Grippe humaine (mortalité), Grossesse (MeSH), Humains (MeSH), Immunosénescence (MeSH), Orthomyxoviridae (MeSH), Planification en santé (MeSH), Sous-type H3N2 du virus de la grippe A (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Vaccins antigrippaux (administration et posologie), Vieillissement (MeSH).
MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Grippe humaine.
- mortalité : Grippe humaine.
- épidémiologie : Allemagne.
- Adjuvants immunologiques, Adulte d'âge moyen, Femelle, Grossesse, Humains, Immunosénescence, Orthomyxoviridae, Planification en santé, Sous-type H3N2 du virus de la grippe A, Sujet âgé, Sujet âgé de 80 ans ou plus, Vieillissement.
Wicri :
- geographic : Allemagne.

English descriptors

KwdEn :
- Adjuvants, Immunologic (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Aging (MeSH), Female (MeSH), Germany (epidemiology), Health Planning (MeSH), Humans (MeSH), Immunosenescence (MeSH), Influenza A Virus, H3N2 Subtype (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (immunology), Influenza, Human (mortality), Middle Aged (MeSH), Orthomyxoviridae (MeSH), Pregnancy (MeSH).
MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical : Adjuvants, Immunologic.
- geographic , epidemiology : Germany.
- immunology : Influenza, Human.
- mortality : Influenza, Human.
- Aged, Aged, 80 and over, Aging, Female, Health Planning, Humans, Immunosenescence, Influenza A Virus, H3N2 Subtype, Middle Aged, Orthomyxoviridae, Pregnancy.

Abstract

In Germany up to 20% of the population are affected by influenza every year. Particularly for the elderly, influenza is related to high morbidity and mortality and 90% of deaths are related to the group of 60 years and older. In this context, seasonal influenza caused by influenza A (H3N2) viruses is exceedingly relevant for the elderly. The aging of the immune system, immunosenescence, is well documented as the cause of increased susceptibility to infection and change of typical symptoms. This can cause a delay in diagnosing and treatment of influenza infections. Furthermore, immunosenescence can lead to decreased efficacy of vaccination. Adjuvanted vaccines and vaccines with higher antigen content cause an enhanced immune response and are therefore especially suitable for prevention. The Standing Vaccination Committee (STIKO) recommends vaccination against seasonal influenza for all persons 60 years of age and over as well as for nursing home residents, pregnant women and chronically ill patients. For the coming influenza season 2018/19, the STIKO generally recommends the administration of quadrivalent (tetravalent) vaccines for the first time.

DOI: 10.1007/s00391-018-1418-4
PubMed: 29951833

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000032
to stream Main, to step Curation: 000032

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Influenza: special aspects in old age].</title>
<author><name sortKey="Kwetkat, A" sort="Kwetkat, A" uniqKey="Kwetkat A" first="A" last="Kwetkat">A. Kwetkat</name>
<affiliation wicri:level="1"><nlm:affiliation>Klinik für Geriatrie, Universitätsklinikum Jena, Bachstr. 18, 07743, Jena, Deutschland. anja.kwetkat@med.uni-jena.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinik für Geriatrie, Universitätsklinikum Jena, Bachstr. 18, 07743, Jena</wicri:regionArea>
<wicri:noRegion>07743, Jena</wicri:noRegion>
<wicri:noRegion>07743, Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin, Deutschland. anja.kwetkat@med.uni-jena.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leischker, A" sort="Leischker, A" uniqKey="Leischker A" first="A" last="Leischker">A. Leischker</name>
<affiliation wicri:level="3"><nlm:affiliation>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Klinik für Geriatrie, Alexianer Krefeld, Krefeld, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinik für Geriatrie, Alexianer Krefeld, Krefeld</wicri:regionArea>
<wicri:noRegion>Krefeld</wicri:noRegion>
<wicri:noRegion>Krefeld</wicri:noRegion>
<wicri:noRegion>Krefeld</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Heppner, H J" sort="Heppner, H J" uniqKey="Heppner H" first="H J" last="Heppner">H J Heppner</name>
<affiliation wicri:level="3"><nlm:affiliation>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Lehrstuhl für Geriatrie, Universität Witten/Herdecke, Witten, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Lehrstuhl für Geriatrie, Universität Witten/Herdecke, Witten</wicri:regionArea>
<wicri:noRegion>Witten</wicri:noRegion>
<wicri:noRegion>Witten</wicri:noRegion>
<wicri:noRegion>Witten</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Geriatrische Klinik und Tagesklinik, Helios Klinikum Schwelm, Schwelm, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Geriatrische Klinik und Tagesklinik, Helios Klinikum Schwelm, Schwelm</wicri:regionArea>
<wicri:noRegion>Schwelm</wicri:noRegion>
<wicri:noRegion>Schwelm</wicri:noRegion>
<wicri:noRegion>Schwelm</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29951833</idno>
<idno type="pmid">29951833</idno>
<idno type="doi">10.1007/s00391-018-1418-4</idno>
<idno type="wicri:Area/Main/Corpus">000032</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000032</idno>
<idno type="wicri:Area/Main/Curation">000032</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000032</idno>
<idno type="wicri:Area/Main/Exploration">000032</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Influenza: special aspects in old age].</title>
<author><name sortKey="Kwetkat, A" sort="Kwetkat, A" uniqKey="Kwetkat A" first="A" last="Kwetkat">A. Kwetkat</name>
<affiliation wicri:level="1"><nlm:affiliation>Klinik für Geriatrie, Universitätsklinikum Jena, Bachstr. 18, 07743, Jena, Deutschland. anja.kwetkat@med.uni-jena.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinik für Geriatrie, Universitätsklinikum Jena, Bachstr. 18, 07743, Jena</wicri:regionArea>
<wicri:noRegion>07743, Jena</wicri:noRegion>
<wicri:noRegion>07743, Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin, Deutschland. anja.kwetkat@med.uni-jena.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leischker, A" sort="Leischker, A" uniqKey="Leischker A" first="A" last="Leischker">A. Leischker</name>
<affiliation wicri:level="3"><nlm:affiliation>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Klinik für Geriatrie, Alexianer Krefeld, Krefeld, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinik für Geriatrie, Alexianer Krefeld, Krefeld</wicri:regionArea>
<wicri:noRegion>Krefeld</wicri:noRegion>
<wicri:noRegion>Krefeld</wicri:noRegion>
<wicri:noRegion>Krefeld</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Heppner, H J" sort="Heppner, H J" uniqKey="Heppner H" first="H J" last="Heppner">H J Heppner</name>
<affiliation wicri:level="3"><nlm:affiliation>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Lehrstuhl für Geriatrie, Universität Witten/Herdecke, Witten, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Lehrstuhl für Geriatrie, Universität Witten/Herdecke, Witten</wicri:regionArea>
<wicri:noRegion>Witten</wicri:noRegion>
<wicri:noRegion>Witten</wicri:noRegion>
<wicri:noRegion>Witten</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Geriatrische Klinik und Tagesklinik, Helios Klinikum Schwelm, Schwelm, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Geriatrische Klinik und Tagesklinik, Helios Klinikum Schwelm, Schwelm</wicri:regionArea>
<wicri:noRegion>Schwelm</wicri:noRegion>
<wicri:noRegion>Schwelm</wicri:noRegion>
<wicri:noRegion>Schwelm</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Zeitschrift fur Gerontologie und Geriatrie</title>
<idno type="eISSN">1435-1269</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjuvants, Immunologic (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Aging (MeSH)</term>
<term>Female (MeSH)</term>
<term>Germany (epidemiology)</term>
<term>Health Planning (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Immunosenescence (MeSH)</term>
<term>Influenza A Virus, H3N2 Subtype (MeSH)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (mortality)</term>
<term>Middle Aged (MeSH)</term>
<term>Orthomyxoviridae (MeSH)</term>
<term>Pregnancy (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adjuvants immunologiques (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Allemagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (mortalité)</term>
<term>Grossesse (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Immunosénescence (MeSH)</term>
<term>Orthomyxoviridae (MeSH)</term>
<term>Planification en santé (MeSH)</term>
<term>Sous-type H3N2 du virus de la grippe A (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vieillissement (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Adjuvants, Immunologic</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Aging</term>
<term>Female</term>
<term>Health Planning</term>
<term>Humans</term>
<term>Immunosenescence</term>
<term>Influenza A Virus, H3N2 Subtype</term>
<term>Middle Aged</term>
<term>Orthomyxoviridae</term>
<term>Pregnancy</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adjuvants immunologiques</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Immunosénescence</term>
<term>Orthomyxoviridae</term>
<term>Planification en santé</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Vieillissement</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In Germany up to 20% of the population are affected by influenza every year. Particularly for the elderly, influenza is related to high morbidity and mortality and 90% of deaths are related to the group of 60 years and older. In this context, seasonal influenza caused by influenza A (H3N2) viruses is exceedingly relevant for the elderly. The aging of the immune system, immunosenescence, is well documented as the cause of increased susceptibility to infection and change of typical symptoms. This can cause a delay in diagnosing and treatment of influenza infections. Furthermore, immunosenescence can lead to decreased efficacy of vaccination. Adjuvanted vaccines and vaccines with higher antigen content cause an enhanced immune response and are therefore especially suitable for prevention. The Standing Vaccination Committee (STIKO) recommends vaccination against seasonal influenza for all persons 60 years of age and over as well as for nursing home residents, pregnant women and chronically ill patients. For the coming influenza season 2018/19, the STIKO generally recommends the administration of quadrivalent (tetravalent) vaccines for the first time.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29951833</PMID>
<DateCompleted><Year>2019</Year>
<Month>08</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>08</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-1269</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>51</Volume>
<Issue>5</Issue>
<PubDate><Year>2018</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Zeitschrift fur Gerontologie und Geriatrie</Title>
<ISOAbbreviation>Z Gerontol Geriatr</ISOAbbreviation>
</Journal>
<ArticleTitle>[Influenza: special aspects in old age].</ArticleTitle>
<Pagination><MedlinePgn>585-596</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00391-018-1418-4</ELocationID>
<Abstract><AbstractText>In Germany up to 20% of the population are affected by influenza every year. Particularly for the elderly, influenza is related to high morbidity and mortality and 90% of deaths are related to the group of 60 years and older. In this context, seasonal influenza caused by influenza A (H3N2) viruses is exceedingly relevant for the elderly. The aging of the immune system, immunosenescence, is well documented as the cause of increased susceptibility to infection and change of typical symptoms. This can cause a delay in diagnosing and treatment of influenza infections. Furthermore, immunosenescence can lead to decreased efficacy of vaccination. Adjuvanted vaccines and vaccines with higher antigen content cause an enhanced immune response and are therefore especially suitable for prevention. The Standing Vaccination Committee (STIKO) recommends vaccination against seasonal influenza for all persons 60 years of age and over as well as for nursing home residents, pregnant women and chronically ill patients. For the coming influenza season 2018/19, the STIKO generally recommends the administration of quadrivalent (tetravalent) vaccines for the first time.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwetkat</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-1931-4328</Identifier>
<AffiliationInfo><Affiliation>Klinik für Geriatrie, Universitätsklinikum Jena, Bachstr. 18, 07743, Jena, Deutschland. anja.kwetkat@med.uni-jena.de.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin, Deutschland. anja.kwetkat@med.uni-jena.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Leischker</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin, Deutschland.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Klinik für Geriatrie, Alexianer Krefeld, Krefeld, Deutschland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Heppner</LastName>
<ForeName>H J</ForeName>
<Initials>HJ</Initials>
<AffiliationInfo><Affiliation>Arbeitsgruppe Impfen, Deutsche Gesellschaft für Geriatrie e. V. (DGG), Berlin, Deutschland.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Lehrstuhl für Geriatrie, Universität Witten/Herdecke, Witten, Deutschland.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Geriatrische Klinik und Tagesklinik, Helios Klinikum Schwelm, Schwelm, Deutschland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Influenza: besondere Aspekte im höheren Lebensalter.</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>06</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Z Gerontol Geriatr</MedlineTA>
<NlmUniqueID>9506215</NlmUniqueID>
<ISSNLinking>0948-6704</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006285" MajorTopicYN="N">Health Planning</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068884" MajorTopicYN="Y">Immunosenescence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Immunologic adjuvants</Keyword>
<Keyword MajorTopicYN="N">Immunosenescence</Keyword>
<Keyword MajorTopicYN="N">Orthomyxoviridae</Keyword>
<Keyword MajorTopicYN="N">Quadrivalent influenza vaccine</Keyword>
<Keyword MajorTopicYN="N">Recommendations, health planning</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year>
<Month>04</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2018</Year>
<Month>06</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2018</Year>
<Month>06</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29951833</ArticleId>
<ArticleId IdType="doi">10.1007/s00391-018-1418-4</ArticleId>
<ArticleId IdType="pii">10.1007/s00391-018-1418-4</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11253156</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2015 Mar;15(3):293-300</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25672568</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Internist (Berl). 2018 Feb;59(2):205-212</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29230484</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Dtsch Med Wochenschr. 2016 Sep;141(20):1451-1454</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27701689</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2011 Jul 12;29(31):5015-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21565245</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2017 Aug 12;390(10095):697-708</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28302313</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2012 Sep 15;176(6):527-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22940713</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Med. 2008 Apr;121(4):258-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18374680</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2008 Oct 16;26(44):5567-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18722492</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immun Ageing. 2018 Jan 22;15:3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29387135</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med J Aust. 2006 Nov 20;185(10 Suppl):S48-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17115952</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin Immunother. 2013 Jan;9(1):128-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23442587</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Geriatr Soc. 2012 Jul;60(7):1260-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22724499</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2015 Jul 15;61(2):171-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25829001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2012 Apr 16;30(18):2908-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22342501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin Immunother. 2015;11(3):553-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25714138</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2007 Sep;28(9):1071-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17932829</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2010 May 26;10:134</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20504306</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2014 Aug 14;371(7):635-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25119609</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Geriatr Gerontol Int. 2012 Apr;12(2):223-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21951819</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2013 Jan 30;31(6):861-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23261045</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2003 May 1;21(16):1769-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12686092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Berlin</li>
</region>
<settlement><li>Berlin</li>
</settlement>
</list>
<tree><country name="Allemagne"><noRegion><name sortKey="Kwetkat, A" sort="Kwetkat, A" uniqKey="Kwetkat A" first="A" last="Kwetkat">A. Kwetkat</name>
</noRegion>
<name sortKey="Heppner, H J" sort="Heppner, H J" uniqKey="Heppner H" first="H J" last="Heppner">H J Heppner</name>
<name sortKey="Heppner, H J" sort="Heppner, H J" uniqKey="Heppner H" first="H J" last="Heppner">H J Heppner</name>
<name sortKey="Heppner, H J" sort="Heppner, H J" uniqKey="Heppner H" first="H J" last="Heppner">H J Heppner</name>
<name sortKey="Kwetkat, A" sort="Kwetkat, A" uniqKey="Kwetkat A" first="A" last="Kwetkat">A. Kwetkat</name>
<name sortKey="Leischker, A" sort="Leischker, A" uniqKey="Leischker A" first="A" last="Leischker">A. Leischker</name>
<name sortKey="Leischker, A" sort="Leischker, A" uniqKey="Leischker A" first="A" last="Leischker">A. Leischker</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000031 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000031 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeAllemagneV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29951833
   |texte=   [Influenza: special aspects in old age].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29951833" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV4

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 17:53:30 2020. Site generation: Sat Mar 27 17:40:37 2021

	Serveur d'exploration sur la grippe en Allemagne
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe en Allemagne

[Influenza: special aspects in old age].

[Influenza: special aspects in old age].

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki